Learn More
Selleck Chemical LLC Cu-CPT22

Supplier: Selleck Chemical LLC S867725MG

CU-CPT22 shows dose-dependent inhibitory effects blocking Pam3CSK4-induced TLR1/2 activation with an IC50 of 0 58 0 09 M while no significant inhibition to TLR2/6 It demonstrates minimal non-specific inhibition against a panel of 10 representative kinases (PDGFRB MET DDR2 SRC MAPK1 PAK1 AKT1 PKC- CAMK1 and PLK4)
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.